Clinical and pharmacological group: & nbsp

Genotoninizing agents and adaptogens

Included in the formulation
  • Befungin
    concentrate inwards 
  • АТХ:

    A.13.A   Tetanus preparations

    Pharmacodynamics:

    A plant-based product, contains pigments and polysaccharides, agaricin and humic-like chaglic acid, as well as trace elements: manganese, copper, cobalt.

    Stimulates leukopoiesis, the immune system. Has a tonic effect on the central nervous system. Normalizes the function of the gastrointestinal tract.

    Under the influence of agaric acid decreases sweating.

    Due to the anesthetic effect it improves the quality of life of cancer patients.

    Pharmacokinetics:

    Not described.

    Indications:

    It is used for the treatment of functional disorders of the gastrointestinal tract, peptic ulcer of the stomach and duodenum, as well as with prolonged immunosuppressive therapy. Used as a symptomatic agent for cancer.

    II.C76-C80.C80   Malignant neoplasm without specification of localization

    XI.K20-K31.K22.4   Dyskinesia of the esophagus

    XI.K20-K31.K25   Stomach ulcer

    XI.K20-K31.K29.5   Chronic gastritis, unspecified

    XI.K20-K31.K26   Duodenal ulcer

    XI.K20-K31.K29   Gastritis and duodenitis

    Contraindications:

    Individual intolerance.

    Carefully:

    Pregnancy and lactation, infantile age.

    Pregnancy and lactation:

    Recommendations for FDA - Category B. It is used with caution in pregnancy and lactation.

    Dosing and Administration:

    Inside, in the form of infusion, 1 tablespoon 3 times a day.

    Side effects:

    Dyspeptic phenomena, allergic reactions.

    Overdose:

    Cases of overdose are not described.

    Treatment is symptomatic.

    Interaction:

    Clinically significant interactions are not described.

    Special instructions:

    During treatment it is recommended to adhere to the milk-vegetable diet with the exception of the diet of meat and fats.

    Instructions
    Up